Mar 21 |
abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update
|
Feb 12 |
abrdn Life Sciences Investors raises dividend by 30% to $0.39
|
Feb 9 |
abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates and abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in Distribution Rate
|
Jan 10 |
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
|
Nov 10 |
Tekla Life Sciences declares $0.30 dividend
|
Oct 27 |
abrdn Announces Its Appointment to Four U.S. Specialist Healthcare Closed-End Funds, New Board of Trustees to the Funds and Fund Name Changes
|
Oct 27 |
Tekla Capital Management LLC Announces Closing of Transaction With abrdn
|
Oct 27 |
Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc.
|